Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.01 USD | -6.94% | -17.96% | -48.98% |
May. 09 | Transcript : Invivyd, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Invivyd, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar Invivyd, Inc.
Upcoming events on Invivyd, Inc.
Past events on Invivyd, Inc.
2024-05-21 08:30 am | Annual General Meeting |
2024-05-20 03:00 pm | H.C. Wainwright BioConnect Investor Conference |
2024-05-09 04:30 pm | Q1 2024 Earnings Call |
2024-05-09 04:01 pm | Q1 2024 Earnings Release |
2024-04-04 05:00 pm | Business Update Call |
2024-03-28 07:00 am | Q4 2023 Earnings Release |
2024-03-22 04:00 pm | PEMGARDA Phase 3 clinical trial results call |
2024-02-08 01:00 pm | Guggenheim Healthcare Talks Biotechnology Conference |
2023-11-30 10:50 am | Evercore ISI HealthCONx Conference |
2023-11-09 04:30 pm | Q3 2023 Earnings Call |
2023-11-09 04:02 pm | Q3 2023 Earnings Release |
2023-11-07 03:50 pm | Guggenheim Securities Inflammation & Immunology Conference |
2023-09-13 12:55 pm | Morgan Stanley Global Healthcare Conference - Fireside Chat |
2023-09-11 03:00 pm | H.C. Wainwright Global Investment Conference - Fireside Chat |
2023-08-10 04:30 pm | Q2 2023 Earnings Call |
2023-08-10 04:01 pm | Q2 2023 Earnings Release |
2023-06-09 11:30 am | Jefferies Global Healthcare Conference |
2023-05-23 08:30 am | Annual General Meeting |
2023-05-11 04:30 pm | Q1 2023 Earnings Call |
2023-05-11 04:01 pm | Q1 2023 Earnings Release |
Annual results
Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 174 |
EBITDA Million USD | Released Forecast Spread | -227 -305 25.6% | -231 -215 -7.27% | -212 -169 -25.5% | -74,6 |
EBIT Million USD | Released Forecast Spread | -227 -255 10.98% | -231 -232 0.69% | -213 -178 -19.24% | -118 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -227 -238 4.72% | -241 -238 -1.46% | -199 -171 -15.94% | -110 |
Net income Million USD | Released Forecast Spread | -227 -238 4.72% | -241 -238 -1.46% | -199 -171 -15.94% | -110 |
EPS USD | Released Forecast Spread | -5,32 -2,22 -140% | -2,23 -2,19 -2.06% | -1,81 -1,56 -15.78% | -0,88 |
Announcement Date | 30/03/22 | 23/03/23 | 28/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 6,00 | 45,1 | 113 | 92,0 | 38,5 |
EBITDA Million USD | Released Forecast Spread | -39,0 -32,1 -21.34% | -53,8 -38,8 -38.54% | -42,9 -60,4 28.91% | -76,6 -42,7 -79.47% | -46,0 -52,7 12.78% | -54,9 | -47,0 | 1,50 | ||||||
EBIT Million USD | Released Forecast Spread | -101 -80,2 -25.63% | -51,7 -62,1 16.6% | -47,3 -54,1 12.58% | -48,2 -43,0 -12.12% | -39,1 -35,5 -9.96% | -53,9 -39,6 -36.05% | -43,1 -57,6 25.2% | -76,8 -48,6 -58.03% | -46,1 -57,6 20.03% | -49,3 | -32,5 | 10,1 | -11,5 | -46,4 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -101 -80,2 -25.59% | -51,0 -62,0 17.74% | -45,1 -53,9 16.36% | -44,6 -43,0 -3.66% | -35,3 -33,0 -7.14% | -50,2 -37,6 -33.76% | -39,4 -56,1 29.63% | -73,7 -46,0 -60.12% | -43,5 -60,9 28.58% | -47,5 | -31,0 | 11,9 | -8,90 | -43,8 |
Net income Million USD | Released Forecast Spread | -101 -80,2 -25.59% | -51,0 -62,0 17.74% | -45,1 -53,9 16.36% | -44,6 -43,0 -3.66% | -35,3 -33,0 -7.14% | -50,2 -37,6 -33.76% | -39,4 -56,1 29.63% | -73,7 -46,0 -60.12% | -43,5 -60,9 28.58% | -47,5 | -31,0 | 11,9 | -8,90 | -43,8 |
EPS USD | Released Forecast Spread | -0,93 -0,73 -28.28% | -0,47 -0,57 17.54% | -0,42 -0,49 14.86% | -0,41 -0,40 -3.8% | -0,32 -0,30 -6.67% | -0,46 -0,35 -33.33% | -0,36 -0,51 29.41% | -0,67 -0,42 -58.27% | -0,38 -0,51 24.75% | -0,36 | -0,26 | 0,08 | -0,05 | -0,26 |
Announcement Date | 13/05/22 | 15/08/22 | 10/11/22 | 23/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 28/03/24 | 09/05/24 | - | - | - | - | - |
Past sector events for Invivyd, Inc.
2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
2024-05-15 04:01 pm | CELCUITY INC.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 08:00 am | IMMUNOME, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IVVD Stock
- Calendar Invivyd, Inc.